Reversion of resistance to immunosuppressive agents in three patients with psoriatic arthritis by cyclosporine A: Modulation of P-glycoprotein function

Clinical Immunology

Volumn 138, Issue 1, 2011, Pages 9-13

  Diamanti, Andrea Picchianti ^a   Rosado, Manuela ^b   Germano, Valentina ^a   Scarsella, Marco ^b   Giorda, Ezio ^b   Podestà, Edoardo ^a   D'Amelio, Raffaele ^a   Carsetti, Rita ^b   Laganà, Bruno ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

Cyclosporine; Drug resistance; P glycoprotein; Rhodamine 123

Indexed keywords

C REACTIVE PROTEIN; CYCLOSPORIN A; GLYCOPROTEIN P; LEFLUNOMIDE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; RHODAMINE 123; SALAZOSULFAPYRIDINE;

ADULT; ARTICLE; CASE REPORT; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; DISEASE ACTIVITY; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN FUNCTION; PSORIATIC ARTHRITIS; TREATMENT OUTCOME;

ADULT; ANTIGENS, CD3; ARTHRITIS, PSORIATIC; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYCLOSPORINE; DRUG RESISTANCE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; JOINTS; MALE; METHOTREXATE; MIDDLE AGED; P-GLYCOPROTEIN; RHODAMINE 123; SULFASALAZINE; T-LYMPHOCYTES; TREATMENT OUTCOME; VERAPAMIL;

EID: 78651350296     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2010.10.001     Document Type: Article

References (7)

1. Olivieri I., Salvarani C., Cantini F., Portioli I. Therapy with cyclosporine in psoriatic arthritis. Semin. Arthritis Rheum. 1997, 27(1):35-43.
2. Ritchlin C.T., Kavanaugh A., Gladman D.D., Mease P.J., Taylor W.J., et al. Treatment recommendations for psoriatic arthritis. Ann. Rheum. Dis. Sep 2009, 68(9):1387-1394.
3. Richaud-Patin Y., Soto-Vega E., Jakez-Ocampo J., Llorente L. P-glycoprotein in autoimmune diseases. Autoimmun. Rev. 2004, 3:188-192.
4. Henmi K., Yoshida M., Yoshikawa N., Hirano T. P-glycoprotein function in peripheral-blood CD4+ cells of patients with systemic lupus erythematosus. Biol. Pharm. Bull. 2008, 31(5):873-878.
5. Gottesman M.M., Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 1993, 62:385-427.
6. Parasrampuria D.A., Lantz M.V., Birnbaum J.L., Benet L.Z.X. Effect of calcineurin inhibitor therapy on P-gp expression and function in lymphocytes of renal transplant patients: a preliminary evaluation. J. Clin. Pharmacol. 2002, 42:304-311.
7. Truffa-Bachi P., Lefkovits I., Frey J.R. Proteomic analysis of T cell activation in the presence of cyclosporin A: immunosuppressor and activator removal induces de novo protein synthesis. Mol. Immunol. Jan-Feb 2000, 37(1-2):21-28.